← Leaderboards
Rui Zheng
Isoplexis, Inc.
$1,187,038
Attributed
$2,374,076
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $996.5K · FY2018–20$1M$750K$500K$250K$0
'18
'19
'20
Funding mix
By agency
NIH$2,374,076 · 3
By mechanism
R44$1,985,450 · 1
R43$388,626 · 2
Top collaborators
- Timothy S Mcconnell4 shared
Most similar at Isoplexis, Inc.
Same institution · by research overlap
- Timothy S McConnell$10,023,361
- Jing Zhou$8,086,644
Others in their field
Other Emerging Leaders on “Sampling”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$181,167,581
- Beth Baseler · Leidos Biomedical Research, Inc.$105,136,677
- Scott Topper · Broad Institute, Inc.$77,958,806
- Paul F Gallagher · Woods Hole Oceanographic Institution$63,916,876
- Leonard Freedman · Leidos Biomedical Research, Inc.$60,323,945
- Dale Sandler · Social And Scientific Systems, Inc.$59,740,435
Research focus
SamplingProteinsMessenger RnaResponseTranscriptome SequencingSuccessImmune ResponseMeasurementPhenotypeProteomicsTechnologyTranscriptomeDevicesTranscriptomicsEvaluationCellsBaseInstrumentComparativeMonitorBiological MarkersCell CountCd8-Positive T-LymphocytesCancer Immunotherapy
Grant awards (4)
Multi-Omic Single-Cell System for Improved Combination Cancer Immunotherapy Monitoring and Implementation$988,980
R44 · FY2020 · CA
Multi-Omic Single-Cell System for Improved Combination Cancer Immunotherapy Monitoring and Implementation$996,470
R44 · FY2019 · CA
A Combined High-Throughput Single-Cell Transcriptomic and Secretomic Assay for Neurodegenerative Disease Biomarker Discovery$224,895
R43 · FY2018 · NS
A High-Throughput, Multi-Omic Assay of Tumor Biomarkers from Single-Cells$163,731
R43 · FY2018 · HG · contact PI